Smallpox vaccine may be developed by Gamaleya Center in 3 to 7 months — expert

ST. PETERSBURG, June 16. /TASS/. Russia’s Gamaleya Center can develop a smallpox vaccine within three to seven months, if it has a corresponding request, Alexander Gintsburg, the Center’s director, told TASS. "We can make a vaccine with the help of adenoviral vectors that were used to develop the Sputnik V coronavirus vaccine. I hope it will not take ten years. If we have such a request, we will be able to do it within three to seven months," he said on the sidelines of the St. Petersburg International Forum. Chief of Russia’s sanitary watchdog Anna Popova said in May that three smallpox vaccines are registered in Russia, with each one of them "working well," but being painful. She also said that the watchdog’s Vector Center had developed a new generation smallpox vaccine, which is expected to give protection against monkeypox. The St. Petersburg International Economic Forum, organized by the Roscongress Foundation, is running on June 15 through 18. This year’s forum is dubbed: ‘New Opportunities in a New World’. A number of other events will take place beyond the business program, among them are the SME Forum, the Creative Business Forum, the Drug Security Forum, the SPIEF Junior Dialogue and SPIEF Sport Week. TASS serves as the event’s official photo hosting agency and the information partner. Read more